Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;8(2):355–365. doi: 10.1111/j.1750-3639.1998.tb00159.x

Corticobasal Ganglionic Degeneration and Progressive Supranuclear Palsy Presenting with Cognitive Decline

Catherine Bergeron 1,2,✉, Andrea Davis 1, Anthony E Lang 3,4,5
PMCID: PMC8098360  PMID: 9546292

Abstract

Corticobasal ganglionic degeneration (CBGD) and progressive supranuclear palsy (PSP) were originally described in the sixties as predominantly motor syndromes. Over the years, the detailed study of additional cases of CBGD has shown that it is a distinctive histological entity which can often present as dementia or aphasia. Although some pathological features of CBGD overlap with those of other forms of non‐Alzheimer non‐Lewy body dementia, the distribution and relative number of these abnormalities and the distinctive pattern of tau immunodeposits allows the distinction of CBGD from Pick's disease and fronto‐temporal dementia. In contrast, PSP only rarely presents with prominent dementia or behavioral changes. In these unusual PSP cases, care must be taken to exclude the diagnoses of CBGD and familial tangle‐only dementia.

Full Text

The Full Text of this article is available as a PDF (187.8 KB).

References

  • 1. . (1985) Case records of the Massachusetts General Hospital. N Engl J Med 313: 739–748. [DOI] [PubMed] [Google Scholar]
  • 2. . (1997) Case records of the Massachusetts General Hospital. N Engl J Med 337: 549–556. [DOI] [PubMed] [Google Scholar]
  • 3. Abe H, Yagishita S, Inoue M, Amano N (1997) A comparison between progressive supranuclear palsy (PSP) and corticobasal degeneration on the cytoskeletal pathology. Brain Pathol 7: 1331. [Google Scholar]
  • 4. Akashi T, Arima K, Maruyama N, Ando S, Inose T (1989) Severe cerebral atrophy in progressive supranuclear palsy: a case report. Clin Neuropathol 8: 195–199. [PubMed] [Google Scholar]
  • 5. Arima K, Uesugi H, Fujita I, Sakurai Y, Oyanagi S, Andoh S, Izumiyama Y, Inose T (1994) Corticonigral degeneration with neuronal achromasia presenting with primary progressive aphasia: ultrastructural and immunocytochemical studies. J Neurol Sci 127: 186–197. [DOI] [PubMed] [Google Scholar]
  • 6. Bergeron C, Pollanen M, Weyer L, Black S, Lang A (1996) Unusual clinical presentations of cortical‐basal ganglionic degeneration. Ann Neurol 40: 893–900. [DOI] [PubMed] [Google Scholar]
  • 7. Bergeron C, Pollanen MS, Weyer L, Lang A (1997) Cortical degeneration in progressive supranuclear palsy. A comparison with cortical‐basal ganglionic degeneration. J Neuropathol Exp Neurol 56: 726–734. [PubMed] [Google Scholar]
  • 8. Boeve B, Parisi J, Maraganore D, Ahlskog J, Caselli R, Graff‐Radford N, Petersen R, Kokmen E (1997) Pathologic findings in 11 cases of clinically suspected cortical‐basal degeneration (CNGD). Brain Pathol 7: 1177. [Google Scholar]
  • 9. Brown J, Lantos P, Roques P, Fidani L, Rossor M (1996) Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study. J Neurol Sci 135: 21–30. [DOI] [PubMed] [Google Scholar]
  • 10. Buée‐Scherrer V, Hof P, Buée L, Leveugle B, Vermesh P, Perl D, Olanow C, Delacourte A (1996) Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. J Neuropathol Exp Neurol 91: 351–359. [DOI] [PubMed] [Google Scholar]
  • 11. Chin SS‐M, Goldman JE (1996) Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 55: 499–508. [DOI] [PubMed] [Google Scholar]
  • 12. Clark AW, Manz HJ, White CL III, Lehmann J, Miller D, Coyle JT (1986) Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease. J Neuropathol Exp Neurol 45: 268–284. [DOI] [PubMed] [Google Scholar]
  • 13. Collins S, Ahlskog J, Parisi J, Maraganore D (1995) Progressive supranuclear palsy: neuropathologically based diagnostic criteria. J Neurol Neurosurg Psychiatry 58:. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Cooper PN, Jackson M, Lennox G, Lowe J, Mann DM (1995) t, ubiquitin, and aB‐Crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Arch Neurol 52: 101–1015. [DOI] [PubMed] [Google Scholar]
  • 15. Daniel S, de Bruin V, Lees A (1995) The clinical and pathological spectrum of Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 118: 759–770. [DOI] [PubMed] [Google Scholar]
  • 16. Davis P, Bergeron C, McLachlan D (1985) Atypical presentation of progressive supranuclear palsy. Ann Neurol 17: 337–343. [DOI] [PubMed] [Google Scholar]
  • 17. Feany M, Ksiezak‐Reding H, Liu W‐K, Vincent I, Yen S‐H, Dickson D (1995) Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol 90: 37–43. [DOI] [PubMed] [Google Scholar]
  • 18. Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146: 1388–1396. [PMC free article] [PubMed] [Google Scholar]
  • 19. Feany MB, Dickson DW (1996) Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol 40: 139–148. [DOI] [PubMed] [Google Scholar]
  • 20. Feany MB, Mattiace LA, Dickson DW (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 55: 53–67. [DOI] [PubMed] [Google Scholar]
  • 21. Flament S, Delacourte A, Verny M, Hauw J‐J, Javoy‐Agid F (1991) Abnormal tau proteins in progressive supranuclear palsy. Acta Neuropathol 81: 591–596. [DOI] [PubMed] [Google Scholar]
  • 22. Gearing M, Olson DA, Watts RL, Mirra SS (1994) Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 44: 1015–1024. [DOI] [PubMed] [Google Scholar]
  • 23. Gibb WRG, Luthert PJ, Marsden CD (1989) Corticobasal degeneration. Brain 112: 1171–1192. [DOI] [PubMed] [Google Scholar]
  • 24. Hanihara T, Amano N, Takahashi T, Nagatomo H, Yagashita S (1995) Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropath Appl Neurobiol 21: 319–326. [DOI] [PubMed] [Google Scholar]
  • 25. Hauw J‐J, Daniel S, Dickson D, Horoupian D, Jellinger K, Lantos P, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele‐Richardson ‐Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015–2019. [DOI] [PubMed] [Google Scholar]
  • 26. Hauw J‐J, Verny M, Delaère P, Cervera P, He Y, Duyckaerts C (1990) Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett 119: 182–186. [DOI] [PubMed] [Google Scholar]
  • 27. Higuchi Y, Iwaki T, Tateishi J (1995) Neurodegeneration in the limbic and paralimbic system in progressive supranuclear palsy. Neuropath Appl Neurobiol 21: 246–254. [DOI] [PubMed] [Google Scholar]
  • 28. Horoupian DS, Chu PL (1994) Unusual case of corticobasal degeneration with tau/Gallyas‐positive neuronal and glial tangles. Acta Neuropathol 88: 592–598. [DOI] [PubMed] [Google Scholar]
  • 29. Ikeda K, Akiyama H, Iritani S, Kase K, Arai T, Niizato K, Kuroki N, Kosaka K (1996) Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus: case report and review. Acta Neuropathol 92: 534–539. [DOI] [PubMed] [Google Scholar]
  • 30. Ishino H, Otsuki S (1976) Frequency of Alzheimer's neurofibrillary tangles in the cerebral cortex in progressive supranuclear palsy (subcortical argyrophilic dystrophy). J Neurol Sci 28: 309–316. [DOI] [PubMed] [Google Scholar]
  • 31. Iwatsubo T, Hasegawa M, Ihara Y (1994) Neuronal and glial tau‐positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol 88: 129–136. [DOI] [PubMed] [Google Scholar]
  • 32. Jackson M, Lowe J (1996) The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 91: 127–134. [DOI] [PubMed] [Google Scholar]
  • 33. Jellinger K (1996) Structural basis of dementia in neurodegenerative disorders. J Neural Transm [Suppl] 47: 1–29. [DOI] [PubMed] [Google Scholar]
  • 34. Kawasaki K, Iwanaga K, Wakabayashi K, Yamada M, Nagai H, Idezuka J, Homma Y, Ikuta F (1996) Corticobasal degeneration with neither argyrophilic inclusions nor tau abnormalities: a new subgroup Acta Neuropathol 91: 140–144. [DOI] [PubMed] [Google Scholar]
  • 35. Kertesz A, Hudson L, Mackenzie IR, Munoz DG (1994) The pathology and nosology of primary progressive aphasia. Neurology 44: 2065–2072. [DOI] [PubMed] [Google Scholar]
  • 36. Komori T, Arai N, Nakayama H, Yagishita S, Shibata N, Kobayashi M, Sasaki S (1997) Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Brain Pathol 7: 1331. [DOI] [PubMed] [Google Scholar]
  • 37. Ksiezak‐Reding H, Morgan K, Mattiace LA, Davies P, Liu W‐K, Yen S‐H, Weidenheim K, Dickson D (1994) Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 145: 1496–1508. [PMC free article] [PubMed] [Google Scholar]
  • 38. Ksiezak‐Reding H, Tracz E, Yang L‐S, Dickson D, Simon M, Wall JS (1996) Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy. Am J Pathol 149: 639–651. [PMC free article] [PubMed] [Google Scholar]
  • 39. Lang A, Bergeron C, Pollanen M, Ashby P (1994) Parietal Pick's disease mimicking corticobasal ganglionic degeneration. Neurology 44: 1436–1440. [DOI] [PubMed] [Google Scholar]
  • 40. Li F, Kosaka K, Nishimura T, Akiyama H, Kato M (1996) Progressive supranuclear palsy with fronto‐temporal atrophy and various tau‐positive abnormal structures. Clin Neuropathol 15: 319–323. [PubMed] [Google Scholar]
  • 41. Lippa CF, Cohen R, Smith TW, Drachman DA (1991) Primary progressive aphasia with focal neuronal aphasia. Neurology 41: 882–886. [DOI] [PubMed] [Google Scholar]
  • 42. Litvan I, Agid I, Jankovic J, Goetz C, Brandel J, Lai E, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri K, McKee A, Jellinger K, Bartko J, Mangone C, Pearce R (1996) Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele‐Richardson‐Olszewski syndrome). Neurology 46: 922–930. [DOI] [PubMed] [Google Scholar]
  • 43. Litvan I, Hauw J, Bartko J, Lantos P, Daniel S, Horoupian D, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson D (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55: 97–105. [DOI] [PubMed] [Google Scholar]
  • 44. Litvan I, Mangone C, McKee A, Verny M, Parsa A, Jellinger K, D'Olhaberriague L, Chaudhuri KR, Pearce R (1996) Natural history of progressive supranuclear palsy (Steele‐Richardson‐Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 61: 615–620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Litvan I, Mega MS, Cummings JL, Fairbanks L (1996) Neuropsychiatrie aspects of progressive supranuclear palsy. Neurology 47: 1184–1189. [DOI] [PubMed] [Google Scholar]
  • 46. Lowe J (1997) Degenerative non‐alzheimer dementias. Brain Pathol 7: 1047–1051. [Google Scholar]
  • 47. Mackenzie I, Hudson L (1995) Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol 90: 615–619. [DOI] [PubMed] [Google Scholar]
  • 48. Mitsuyama Y, Masuda K, Inoue T, Koono M, Koga S, Nakamura J (1992) Primary progressive dementia with swollen chromatolytic neurons. Dementia 3: 223–231. [Google Scholar]
  • 49. Mori H, Nishimura M, Namba Y, Oda M (1994) Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol 88: 113–121. [DOI] [PubMed] [Google Scholar]
  • 50. Mori H, Oda M, Mizuno Y (1995) Cortical ballooned neurons in progressive supranuclear palsy. Neurosci Lett 209: 109–112. [DOI] [PubMed] [Google Scholar]
  • 51. Nishimura T, Ikeda K, Akiyama H, Arai T, Kondo H, Okochi M, Furiya Y, Mori H, Oda T, Kato M, Iseki E (1997) Glial tau‐positive structures lack the sequence encoded by exon 3 of the tau protein gene. NeurosciLett 224: 169–172. [DOI] [PubMed] [Google Scholar]
  • 52. Nishimura T, Ikeda K, Akiyama H, Kondo H, Kato M, Li F, Iseki E, Kosaka K (1995) Immunohistochemical investigation of tau‐positive structures in the cerebral cortex of patients with progressive supranuclear palsy. Neurosci Lett 201: 123–126. [DOI] [PubMed] [Google Scholar]
  • 53. Paulus W, Selim M (1990) Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol 81: 89–94. [DOI] [PubMed] [Google Scholar]
  • 54. Rebeiz J, Kolodny E, Richardson E (1967) Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder in late adult life. Trans Am Neurol Assoc 92: 23–26. [PubMed] [Google Scholar]
  • 55. Rebeiz JJ, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20–33. [DOI] [PubMed] [Google Scholar]
  • 56. Reed LA, Grabowski TJ, Schmidt ML, Morris JC, Goate A, Solodkin A, van Hoesen GW, Schelper RL, Talbot CJ, Wragg MA, Trojanowski JQ (1997) Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 42: 564–572. [DOI] [PubMed] [Google Scholar]
  • 57. Riley D, Lang A, Lewis A, Resh L, Ashby P, Hornykiewicz O, Black S (1990) Cortical‐basal ganglionic degeneration. Neurology 40: 1203–1212. [DOI] [PubMed] [Google Scholar]
  • 58. Rinne J, Lee M, Thompson P, Marsden C (1994) Corticobasal degeneration. A clinical study of 36 cases. Brain 117: 1183–1196. [DOI] [PubMed] [Google Scholar]
  • 59. Schneider J, Watts R, Gearing M, Brewer R, Mirra S (1997) Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 48: 959–969. [DOI] [PubMed] [Google Scholar]
  • 60. Steele J, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. Arch Neurol 10: 333–359. [DOI] [PubMed] [Google Scholar]
  • 61. Takeuchi T, Shibayama H, Iwai K, Iwata H, Xu M, Kitoh J, Kobayashi H, Iwase S, Nakagawa N, Yoshida K, Nambu Y, Ishihara R (1992) Progressive supranuclear palsy with widespread cerebral lesions. Clin Neuropathol 11: 304–312. [PubMed] [Google Scholar]
  • 62. Tissot R, Constantidinis J, Richard J (1975) La maladie de Pick, Masson et Cie: Paris . [Google Scholar]
  • 63. Uchihara T, Mitani K, Mori H, Kondo H, Yamada M, Ikeda K (1994) Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy. Acta Neuropathol 88: 379–383. [DOI] [PubMed] [Google Scholar]
  • 64. Verny M, Duyckaerts C, Agid Y, Hauw J‐J (1996) The significance of cortical pathology in progressive supranuclear palsy. Brain 119: 1123–1136. [DOI] [PubMed] [Google Scholar]
  • 65. Verny M, Jellinger K, Hauw J, Bancher C, Litvan I, Agid Y (1996) Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol 91: 427–431. [DOI] [PubMed] [Google Scholar]
  • 66. Wakabayashi K, Oyanagi K, Makifuchi T, Ikuta F, Homma A, Homma Y, Horikawa Y, Tokiguchi S (1994) Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol 87: 545–553. [DOI] [PubMed] [Google Scholar]
  • 67. Yamada T, McGeer P, McGeer E (1992) Appearance of paired nucleated, tau‐positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett 135: 99–102. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES